Lv41
450 积分 2022-02-06 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
2个月前
已完结
Biology and regulation of IL-2: from molecular mechanisms to human therapy
2个月前
已完结
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
2个月前
已完结
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
2个月前
已完结
Development of an 18F-labeled anti-human CD8 VHH for same-day immunoPET imaging
4个月前
已完结
Pan‐HER—An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand‐induced EGFR homo‐ and heterodimers
5个月前
已完结
Development of Novel Antibody-Camptothecin Conjugates
6个月前
已完结
A Comparative Review of PSA, PSMA PET, and PCA3 Biomarkers in Prostate Cancer Diagnosis: Effectiveness, Cost, and Safety Analysis
6个月前
已关闭
Sequential immunotherapy: towards cures for autoimmunity
7个月前
已完结
皖公网安备34019202002308
